Registered number
06897080
Nirvana Health Limited
Filleted Accounts
31 March 2025
Nirvana Health Limited
Registered number: 06897080
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
As restated
Fixed assets
Tangible assets 3 15,004 18,760
Investment property 4 696,734 696,734
711,738 715,494
Current assets
Stocks 157,250 122,490
Debtors 5 38,620 49,107
Cash at bank and in hand 58,842 37,992
254,712 209,589
Creditors: amounts falling due within one year 6 (337,013) (320,885)
Net current liabilities (82,301) (111,296)
Total assets less current liabilities 629,437 604,198
Creditors: amounts falling due after more than one year 7 (325,322) (325,322)
Net assets 304,115 278,876
Capital and reserves
Called up share capital 150 150
Share premium 29,000 29,000
Profit and loss account 274,965 249,726
Shareholders' funds 304,115 278,876
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Rinesh Shashikant Doshi
Director
Approved by the board on 15 October 2025
Nirvana Health Limited
Notes to the Accounts
for the year ended 31 March 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings, tools and equipment 20% reducing balance
Investment properties
"Investment properties are properties held to earn rentals and/or for capital appreciation. The properties are initially measured at cost, including transaction costs.

Subsequently investment properties whose fair value can be measured reliably without undue cost or effort on an on-going basis are measured at fair value. Gains and losses arising from changes in the fair value of investment properties are included in revaluation reserves in the period in which they arise; and no depreciation is provided in respect of investment properties applying the fair value model.

Investment property fair value is determined by the director based on his understanding of property market conditions and derived from current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific assets."
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Leased assets
Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Functional and presentation currency
The financial statements of the company are measured and presented in the currency of the primary economic environment in which the company operates, the functional currency. The financial statements are presented in Pound sterling (£), which is the company’s functional currency.
Employee benefits
Short-term employee benefits
Short-term employee benefits are recognised as an expense in the period in which they are incurred.

Post-employment defined contribution plans
Amounts in respect of defined contributions plans are recognised as an expense as they are incurred.

Termination benefits
Provisions for termination benefits are recognised only when the company is demonstrably committed to terminate the employment of an employee or of a group of employees before their normal retirement date or to provide termination benefits as a result of an offer made in order to encourage voluntary redundancy.
Going concern
The financial statements have been prepared on the basis that the company will receive continued financial support from bank and directors and has adequate resources to continue in operational existence for the foreseeable future.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 5 5
3 Tangible fixed assets
Fixtures, fittings, tools and equipment
£
As restated
Cost
At 1 April 2024 60,423
At 31 March 2025 60,423
Depreciation
At 1 April 2024 41,663
Charge for the year 3,756
At 31 March 2025 45,419
Net book value
At 31 March 2025 15,004
At 31 March 2024 18,760
4 Investment property
Investment
property
£
Cost
At 1 April 2024 696,734
At 31 March 2025 696,734
5 Debtors 2025 2024
£ £
Trade debtors 23,351 33,549
Other debtors 15,269 15,558
38,620 49,107
6 Creditors: amounts falling due within one year 2025 2024
£ £
Bank loans and overdrafts 65,286 58,193
Trade creditors 150,524 172,465
Corporation tax 8,145 12,091
Other taxes and social security costs 3,757 2,651
Other creditors 109,301 75,485
337,013 320,885
7 Creditors: amounts falling due after one year 2025 2024
£ £
Bank loans 325,322 325,322
8 Related party transactions
Included within other creditors is a directors' loan of £84,058 (2024 - £40,385).
9 Controlling party
The directors do not consider there to be an ultimate controlling party.
10 Other information
Nirvana Health Limited is a private company limited by shares and incorporated in England. Its registered office is:
321 Green Lanes
Palmers Green
London
N13 4TY
Nirvana Health Limited 06897080 false 2024-04-01 2025-03-31 2025-03-31 VT Final Accounts April 2024 Rinesh Shashikant Doshi No description of principal activity 06897080 2023-04-01 2024-03-31 06897080 core:WithinOneYear 2024-03-31 06897080 core:AfterOneYear 2024-03-31 06897080 core:ShareCapital 2024-03-31 06897080 core:SharePremium 2024-03-31 06897080 core:RetainedEarningsAccumulatedLosses 2024-03-31 06897080 2024-04-01 2025-03-31 06897080 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06897080 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 06897080 bus:Director40 2024-04-01 2025-03-31 06897080 1 2024-04-01 2025-03-31 06897080 2 2024-04-01 2025-03-31 06897080 core:PlantMachinery 2024-04-01 2025-03-31 06897080 countries:England 2024-04-01 2025-03-31 06897080 bus:FRS102 2024-04-01 2025-03-31 06897080 bus:FilletedAccounts 2024-04-01 2025-03-31 06897080 2025-03-31 06897080 core:WithinOneYear 2025-03-31 06897080 core:AfterOneYear 2025-03-31 06897080 core:ShareCapital 2025-03-31 06897080 core:SharePremium 2025-03-31 06897080 core:RetainedEarningsAccumulatedLosses 2025-03-31 06897080 core:PlantMachinery 2025-03-31 06897080 2024-03-31 06897080 core:PlantMachinery 2024-03-31 iso4217:GBP xbrli:pure